Recently we synthesized a series of dioxane-triazole antifungal agents, which are effective against systemic mycoses.
Recently we synthesized a series of dioxane-triazole antifungal agents, which are effective against systemic mycoses. 1) From such compounds, R-102557 (3d) was chosen as a candidate compound for development on the basis of its in vivo activities in mice. Since it was found that R-102557's high in vivo activities were caused by its excessively long elimination half-life in plasma, 2) we determined to search for a similar compound but with a shorter half-life. In this paper, we will describe the synthesis and in vitro antifungal activities of our new compound CS-758 (3j; former name, R-120758), 3) which is currently under development as an antifungal agent against systemic mycoses.
Starting our search, our attention was focused on minimun inhibitory concentrations (MICs) because as the elimination half-life in plasma gets shorter, the requirements for MICs become severer. We reasoned that, even if a compound with good MICs were to exhibit only fair in vivo activities in mice, the compound might still be able to remain sufficiently long in humans to exhibit reasonable therapeutic effects. On this assumption, some of the previous compounds, such as 3b-g, 1) were re-evaluated on the basis of MICs. Their precursor 1a was also submitted for MIC determination. Some additional compounds, such as 2a, 3a, 3h-j, were prepared.
Preparation of the compounds 2a, 3a, 3h-j were done in acetalization reactions of 4 with aldehydes 5a, 6a, 6h-j, respectively (Chart 2). Previously, molecular sieves were then used to remove water, 1) but this time we conducted the reaction by concentrating a tetrahydrofuran (THF) solution containing 4, the aldehydes, and p-toluenesulfonic acid in a rotary evaporator. Aldehyde 6j, a precursor of CS-758, was The MICs of the compounds with various side chain lengths were determined against clinically important pathogenic fungi (Table 1 ). An unsubstituted phenyl group was first selected as the Ar group and compounds 1a (nϭ0), 2a (nϭ1), and 3a (nϭ2) were compared. Compound 3a with two olefinic double bonds (nϭ2) showed the best MICs. 4) The difference was most clear in the activity against Cryptococcus neoformans.
Synthesis and in Vitro
We then fixed n to 2, and compared the MICs of the derivatives 3b-f having various substituents at the C4 position on the benzene ring Ar ( Table 2 ). The compound with a cyano group (3f) showed remarkable effect with excellent MICs. The difference was the most clear in the activity against Aspergillus fumigatus.
We finally introduced a fluorine atom to the C2 position on the benzene ring to obtain CS-758 (3j). The aim of the fluorine atom was to improve the solubility and chemical/metabolic stability.
5) CS-758 (3j) showed comparable MICs to those of 3f. Analogs 3g-i, with a fluorine atom at the C2 position but without a cyano group at the C4 position, showed lower activities. The excellent MIC of 3g against Cryptococcus neoformans was an exception.
The MICs of CS-758, fluconazole, and itraconazole against 12 fungal strains are listed in Table 3 . The MICs of CS-758 were excellent and surpassed those of the reference drugs. Further evaluations are under way.
Experimental
Melting points were determined with a Yanagimoto micro melting point apparatus and are uncorrected. IR spectra were recorded on a Nic 5SCX spectrometer.
1 H-NMR spectra were recorded either on a JEOL GX-270 (270 MHz), on a Varian Mercury 400 (400 MHz), or on a JNM GSX-400 (400 MHz) spectrometer using tetramethylsilane as an internal standard. The abbreviations are as follows: s, singlet; d, doublet; dd, doublet of doublets; ddd, doublet of doublets of doublets; t, triplet; dt, doublet of triplets; td, triplet of doublets; tt, triplet of triplets; q, quartet; m, multiplet; br, broad. MS and high-resolution MS (HR-MS) were recorded either on a JEOL JMS D300, on a JEOL BU30, or on a JEOL JMS-700 spectrometer. Column chromatography was carried out on silica gel (Kieselgel 60, 0.040-0.063 mm, Merck). The amounts of silica gel used are shown in parentheses.
( 1-(1H-1,2,4-triazol-1-yl)-2-butanols (3a, 3h, 3i ) As a typical example, the preparation of 2a is described. A solution of (2R,3R)-
2R,3R)-2-(2,4-Difluorophenyl)-3-[[trans-2-[(E )-styryl]-1,3-dioxan-5-yl]thio]-1-(1H-1,2,4-triazol-1-yl)-2-butanol (2a) and (2R,3R)-2-(2,4-Difluorophenyl)-3-[[trans-2-[(2E,4E )-5-aryl-2,4-pentadienyl]-1,3-dioxan-5-yl]thio]-
1) (E)-cinnamaldehyde (5a; 404 mg, 3.06 mmol), and p-toluenesulfonic acid monohydrate (581 mg, 3.05 mmol) in THF (10 ml) was allowed to stand at room temperature for 5 min, and then concentrated in vacuo using a rotary evaporator to remove water azeotropically. Similar processes (addition of THF and concentration) were repeated two more times. The residual oil was dissolved in THF and cautiously poured into a stirred aqueous solution of NaHCO 3 at 0°C. The mixture was partitioned between EtOAc and water. The organic layer was washed with brine and dried over MgSO 4 . Evaporation of the solvent afforded an oily residue, which was chromatographed on silica gel (60 g). Elution with a mixture of EtOAc and hexane 6) In a 2000 ml round-bottomed Pyrex glass flask fitted with a condenser, a mixture of 3-fluoro-4-methylbenzonitrile (7; 96 g, 710 mmol), N-bromosuccinimide (NBS; 126 g, 708 mmol), 2,2Ј-azobis(isobutyronitrile) (AIBN; 1.2 g, 7 mmol) and 1,2-dichloroethane (1000 ml) was stirred with a magnetic stirrer and irradiated with a tungsten lamp (375 W). The mixture was allowed to warm by the light of the lamp. When the mixture started to reflux, the lamp was occasionally turned off to prevent violent refluxing. After 20 min of refluxing, the redbrown color of the bromine disappeared and the solution became yellow. The mixture was irradiated for 5 min further, and then allowed to cool to room temperature. The mixture was then cooled with ice, and the precipitated succinimide was removed by filtration. The filtrate was partitioned between EtOAc and 10% (w/w) NaCl. The organic layer was dried over MgSO 4 and solvents were removed in vacuo to afford a crude solid, which was recrystallized from hexane-EtOAc to afford 8 (96 g, 63% yield) as colorless needles, mp 71-74°C. Anal. Fluoro-4-[(1E,3E)-5-oxo-1,3 -pentadienyl]benzonitrile (6j) A solution of butyllithium (1.53 N in hexane, 0.5 ml, 0.77 mmol) was added in drops to a stirred solution of 9 (209 mg, 0.77 mmol) in dry THF (4 ml) at Ϫ78°C. After the solution was stirred at Ϫ78°C for 30 min, a solution of fumaraldehyde mono(dimethylacetal) (10; 100 mg, 0.77 mmol) in dry THF (2 ml) was added in drops. The whole was stirred for 2 h at Ϫ78°C, and then stirred in an ice bath for 15 min. Then, the reaction was quenched by adding an aqueous solution of 0.1 N HCl (3.9 ml). The mixture was stirred again in the ice bath for 30 min, and then at room temperature for 1 h. Then the mixture was cooled with ice and treated with a saturated NaHCO 3 solution. The 4-[(1E,3E )-4-[trans-5-[[(1R,2R )-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]thio]-1,3-dioxan-2-yl]-1,3-butadienyl]-3-fluorobenzonitrile (CS-758, 3j) A mixture of 4 (8.73 g, 24.3 mmol), 6j (4.63 g, 23.0 mmol) and p-toluenesulfonic acid monohydrate (5.07 g, 26.7 mmol) in dry THF (200 ml) was allowed to stand at room temperature for 30 min. Then the solvent was removed using a rotary evaporator. The residue was suctioned using a vacuum pump at room temperature to afford an oily residue. Similar evaporation cycles (addition of THF, allowing the mixture to stand, and evaporation) were repeated two more times. To the residue, THF (150 ml) was added, and the solution was poured slowly into a stirred aqueous solution of saturated NaHCO 3 at 0°C. The product was extracted with EtOAc. The organic layer was washed with brine. The extract was dried over MgSO 4 and solvents were removed in vacuo to afford a pale yellow oil, which was chromatographed on silica gel (500 g, hexane-AcOEt Microplates (96 wells) were inoculated at a concentration of 1-5ϫ10 3 cells/ml for Candida species, ca. 1ϫ10 4 cells/ml for C. neoformans, and 2.5ϫ10 4 spores/ml for Aspergillus species, and incubated at 35°C (for Aspergillus species: 30°C). The MICs were read when obvious growth was observed in compound-free control wells. The MICs were defined as the lowest compound concentrations causing at least 80% growth inhibition compared with the control.
4-(Bromomethyl)-3-fluorobenzonitrile (8)

